Serum Ang-2 was clearly overexpressed in breast cancer patients compared to benign breast disease patients, but there was no evidence of an existing relationship between serum Ang-2 levels and clinical-pathologic parameters of breast cancer. The gene discussed is ANGPT2; the disease is breast fibrocystic disease.